Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Ovarian Neoplasms 2Uveal Melanoma 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Hyperthermia 1Fallopian Tube Neoplasms 1Eye Neoplasms 1Carcinoma, Ovarian Epithelial 1Burkitt Lymphoma 1

Interventions

Diathermy 5Radiotherapy 2Immunotherapy 2Immune Checkpoint Inhibitors 2Cisplatin 2tislelizumab 1sodium thiosulfate 1anlotinib 1Surgical Procedures, Operative 1Radiation Dose Hypofractionation 1Radiation 1Laparotomy 1Ifosfamide 1Fluorouracil 1Drug Therapy 1Doxorubicin 1Docetaxel 1Dacarbazine 1Cytoreduction Surgical Procedures 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Hyperthermia × Laparotomy × Clear all
NCT00062933 2012-08-20

A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
40 enrolled
Dermatologic

Hyperthermia, Uveal Melanoma, Eye Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡